Abstract

BackgroundWard pharmacists are required for the active implementation of therapeutic drug monitoring (TDM). This epidemiological study verified whether Japanese ward pharmacists contribute to improving the TDM implementation proportions of anti-methicillin-resistant Staphylococcus aureus (MRSA) agents using the large health insurance claims database.MethodsThe patients who received intravenous anti-MRSA agents from April 2012 to March 2017 were enrolled. We defined ward pharmacy service as the “drug management and guidance fee” and/or “inpatient pharmaceutical services premium”. In addition, implementation of TDM was identified by “the specific drug treatment management fee”. We compared the proportions of TDM implementation for vancomycin (VCM), teicoplanin (TEIC), and arbekacin (ABK) in the ward and non-ward pharmacy service groups. To avoid confounding, the propensity score method was employed. Moreover, the clinical variables affecting TDM implementation in each anti-MRSA agent were analyzed by using a multiple logistic regression model.ResultsThe following number of patients were included in the study: VCM (n = 2138), TEIC (n = 596), and ABK (n = 142). After propensity score matching, the proportions of TDM implementation for VCM and TEIC were higher in the ward pharmacy service group than in the non-ward pharmacy service group (VCM: 69.2% vs 60.3%, TEIC: 51.4% vs 34.7%), while no significant difference was observed for ABK (21.2% vs 23.1%). As independent clinical variables affecting TDM implementation for VCM and TEIC, several clinical variables, including ward pharmacy services, were extracted. In contrast, no clinical variables were extracted for ABK.ConclusionsWe found that the ward pharmacy service is associated with the active implementation of TDM for anti-MRSA agents, such as VCM and TEIC.

Highlights

  • Ward pharmacists are required for the active implementation of therapeutic drug monitoring (TDM)

  • No significant differences were observed for any anti-methicillin-resistant Staphylococcus aureus (MRSA) agents between the ward pharmacy service group and the non-ward pharmacy service group upon propensity score matching

  • The proportion of TDM implementation for VCM and TEIC was significantly higher in the ward pharmacy service group than that in the non-ward pharmacy service group (VCM: 69.2 and 60.3%, TEIC: 51.4 and 34.7%, respectively, after propensity score matching)

Read more

Summary

Introduction

Ward pharmacists are required for the active implementation of therapeutic drug monitoring (TDM). Okada et al validated the effectiveness of hematological ward pharmacist interventions of antiMRSA agents, such as VCM and teicoplanin (TEIC) [8]. They showed that the proportion of achieving the therapeutic range was significantly improved by pharmacist intervention [8]. These results strongly indicated that pharmacists could contribute to improving the efficacy and safety of anti-MRSA agents by TDM implementation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call